Tailored Glycopolymers as Anticoagulant Heparin Mimetics

被引：86
|
作者：
Oh, Young In [1 ,2 ]
Sheng, Gloria J. [1 ,2 ]
Chang, Shuh-Kuen [3 ]
Hsieh-Wilson, Linda C. [1 ,2 ]
机构：
[1] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA
[2] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA
[3] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA
来源：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2013年 / 52卷 / 45期
基金：
美国国家卫生研究院;
关键词：
anticoagulant; biomimetic synthesis; drug discovery; glycopolymers; heparin; MOLECULAR-WEIGHT HEPARIN; CHONDROITIN SULFATE; HIGH-AFFINITY; ANTITHROMBIN; PENTASACCHARIDE; OLIGOSACCHARIDES; GENERATION; LIGANDS; BINDING; PROBES;
D O I：
10.1002/anie.201306968
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Not to clot: Heparin and its low-molecular-weight derivatives are clinical therapeutics used to treat and prevent blood clots. The synthesis of heparin-based glycopolymers that are potent and potentially safer mimetics of heparin is described. The mimetics exhibited activity against proteases (FXa and FIIa) in the coagulation cascade and prolonged blood clot times in human plasma with efficacies similar to those of clinical anticoagulants. ATIII=antithrombin-III. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码：11796 / 11799
页数：4
相关论文
共 50 条
  • [1] Heparin mimetics with anticoagulant activity
    Al Nahain, Abdullah
    Ignjatovic, Vera
    Monagle, Paul
    Tsanaktsidis, John
    Ferro, Vito
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (05) : 1582 - 1613
  • [2] Anticoagulant Heparin Mimetics via RAFT Polymerization
    Al Nahain, Abdullah
    Ignjatovic, Vera
    Monagle, Paul
    Tsanaktsidis, John
    Vamvounis, George
    Ferro, Vito
    BIOMACROMOLECULES, 2020, 21 (02) : 1009 - 1021
  • [3] The non-anticoagulant promise of heparin and its mimetics
    Mulloy, Barbara
    CURRENT OPINION IN PHARMACOLOGY, 2019, 46 : 50 - 54
  • [4] Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties
    Avci, FY
    Karst, NA
    Linhardt, RJ
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (28) : 2323 - 2335
  • [5] Heparin Affin Regulatory Peptide Modulates the Endogenous Anticoagulant Activity of Heparin and Heparan Sulphate Mimetics
    Mejdoubi-Charef, Najet
    Courty, Jose
    Sineriz, Fernando
    Papy-Garcia, Dulce
    Charef, Said
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (05) : 296 - 302
  • [6] Development of glycosaminoglycan mimetics using glycopolymers
    Yoshiko Miura
    Tomohiro Fukuda
    Hirokazu Seto
    Yu Hoshino
    Polymer Journal, 2016, 48 : 229 - 237
  • [7] Development of glycosaminoglycan mimetics using glycopolymers
    Miura, Yoshiko
    Fukuda, Tomohiro
    Seto, Hirokazu
    Hoshino, Yu
    POLYMER JOURNAL, 2016, 48 (03) : 229 - 237
  • [8] Sulfonated RAFT Copolymers as Heparin Mimetics: Synthesis, Reactivity Ratios, and Anticoagulant Activity
    Al Nahain, Abdullah
    Ignjatovic, Vera
    Monagle, Paul
    Tsanaktsidis, John
    Vamvounis, George
    Ferro, Vito
    MACROMOLECULAR BIOSCIENCE, 2020, 20 (09)
  • [9] Heparin Affin Regulatory Peptide Modulates the Endogenous Anticoagulant Activity of Heparin and Heparan Sulphate Mimetics (vol 111, pg 296, 2012)
    Mejdoubi-Charef, Najet
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (02) : 144 - 144
  • [10] End-functionalized glycopolymers as mimetics of chondroitin sulfate proteoglycans
    Lee, Song-Gil
    Brown, Joshua M.
    Rogers, Claude J.
    Matson, John B.
    Krishnamurthy, Chithra
    Rawat, Manish
    Hsieh-Wilson, Linda C.
    CHEMICAL SCIENCE, 2010, 1 (03) : 322 - 325
12345